At the news
? NEUTRALIMPACT 2/10 8-K filed Jul 31, 2026 at 08:48 ET
Vistagen Therapeutics appointed Douglas J. Williamson, M.D. to its Board of Directors effective July 29, 2026. Dr. Williamson received stock options to purchase 40,826 shares at $0.2433 per share, vesting over three years. This is a routine board appointment with no material financial or operational impact.
- Douglas J. Williamson, M.D. appointed to the Board of Directors on July 29, 2026.
- Received options to purchase 40,826 shares of common stock at an exercise price of $0.2433 per share (closing price on appointment date).
- Options vest in equal annual installments over three years, fully vested on the three-year anniversary.
- Dr. Williamson also entitled to annual cash compensation and equity awards under the Director Compensation Plan.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access